GlassScriptPhysician profile
Beth Ellen Rundquist
NPI 1063419463
$2,426.90
in general payments reported to CMS, 2019-2025
18 companies · $265 in 2025
The $265 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $399 · 2021: $272 · 2022: $473 · 2023: $226 · 2024: $545 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $687.20 | 2021-2024 | Qelbree |
| Corium, LLC | $377.33 | 2021-2025 | Azstarys |
| Neos Therapeutics, LP | $188.20 | 2019-2022 | |
| Glaxosmithkline, LLC. | $179.87 | 2019-2023 | Rotarix, Pediarix, Bexsero |
| Cranial Technologies, INC | $170.93 | 2019-2022 | |
| Sanofi Pasteur INC. | $137.96 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $121.78 | 2019-2022 | |
| Organon LLC | $108.05 | 2021-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $79.16 | 2019-2023 | Gardasil 9, Vaxneuvance, Vaxelis |
| Tris Pharma INC | $72.93 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $62.52 | 2025 | Jornay Pm |
| Pfizer INC. | $62.03 | 2020-2025 | |
| Ironshore Pharmaceuticals INC. | $61.29 | 2019-2024 | |
| Adlon Therapeutics L.P. | $45.45 | 2020 | |
| Sobi, INC | $21.54 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.26 | 2022 | |
| Noven Therapeutics, LLC | $19.25 | 2024 | Xelstrym |
| Vertical Pharmaceuticals, LLC | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Rundquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.